Patents by Inventor Bruce A. Bach

Bruce A. Bach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarker of Survival in the Treatment of Renal Cell Carcinoma with a VEGFR Inhibitor and an Ang2 Inhibitor
    Publication number: 20190004048
    Abstract: The present invention relates to methods, compositions, and kits for using placental growth factor (PLGF) as an informative biomarker in determining the clinical benefit to renal cell carcinoma patients by treatment with a VEGFR inhibitor and an Ang2 inhibitor.
    Type: Application
    Filed: June 22, 2016
    Publication date: January 3, 2019
    Applicant: AMGEN INC.
    Inventors: Abraham Antonio ANDERSON, Bruce A. BACH, Cheryl A. PICKETT-GIES, Michael B. BASS
  • Detecting immunological changes in HIV infected patient samples
    Patent number: 5156951
    Abstract: The present invention comprises a method for detecting immunological changes in blood samples from patients infected with HIV. The method comprises the use of fluorescently labelled monoclonal antibodies against IL-2R (CD25). Other antibodies, including anti-CD3, anti-CD38 and anti-HLA DR antibodies also may be used. It has been found that a decrease in expression of CD25 in such samples indicates HIV infection.
    Type: Grant
    Filed: July 13, 1989
    Date of Patent: October 20, 1992
    Assignee: Becton Dickinson and Company
    Inventors: Bruce A. Bach, Noel L. Warner, Anne Jackson